FI853913A0 - Farmaceutiska foereningar som antracyklinglykosider. - Google Patents

Farmaceutiska foereningar som antracyklinglykosider.

Info

Publication number
FI853913A0
FI853913A0 FI853913A FI853913A FI853913A0 FI 853913 A0 FI853913 A0 FI 853913A0 FI 853913 A FI853913 A FI 853913A FI 853913 A FI853913 A FI 853913A FI 853913 A0 FI853913 A0 FI 853913A0
Authority
FI
Finland
Prior art keywords
antracyklinglykosider
foereningar
som
pharmaceutical
som antracyklinglykosider
Prior art date
Application number
FI853913A
Other languages
English (en)
Other versions
FI853913A (fi
Inventor
Gaetano Gatti
Diego Oldani
Carlo Confalonieri
Luciano Gambini
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of FI853913A0 publication Critical patent/FI853913A0/fi
Publication of FI853913A publication Critical patent/FI853913A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI853913A 1984-10-22 1985-10-08 Farmaceutiska foereningar som antracyklinglykosider. FI853913A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848426672A GB8426672D0 (en) 1984-10-22 1984-10-22 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
FI853913A0 true FI853913A0 (fi) 1985-10-08
FI853913A FI853913A (fi) 1986-04-23

Family

ID=10568553

Family Applications (2)

Application Number Title Priority Date Filing Date
FI853913A FI853913A (fi) 1984-10-22 1985-10-08 Farmaceutiska foereningar som antracyklinglykosider.
FI854035A FI86252C (fi) 1984-10-22 1985-10-16 Foerfarande foer foerbaettring av en antracyklinglykosids upploesbarhet i en foer injektering laemplig loesningsmedelsblandning.

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI854035A FI86252C (fi) 1984-10-22 1985-10-16 Foerfarande foer foerbaettring av en antracyklinglykosids upploesbarhet i en foer injektering laemplig loesningsmedelsblandning.

Country Status (35)

Country Link
US (4) US4675311A (fi)
JP (1) JPH0611700B2 (fi)
KR (1) KR920005813B1 (fi)
CN (1) CN85107562B (fi)
AT (1) AT401345B (fi)
AU (1) AU572003B2 (fi)
BE (1) BE903484A (fi)
BG (1) BG60934B2 (fi)
CA (1) CA1248453A (fi)
CH (1) CH667594A5 (fi)
CS (1) CS270421B2 (fi)
DE (1) DE3536896C2 (fi)
DK (1) DK165620C (fi)
ES (1) ES8605374A1 (fi)
FI (2) FI853913A (fi)
FR (1) FR2571966B1 (fi)
GB (2) GB8426672D0 (fi)
GR (1) GR852549B (fi)
HK (1) HK94390A (fi)
HU (1) HU197988B (fi)
IE (1) IE56992B1 (fi)
IL (1) IL76732A (fi)
IT (1) IT1186779B (fi)
MY (1) MY103956A (fi)
NL (1) NL191308C (fi)
NO (1) NO170616C (fi)
NZ (1) NZ213885A (fi)
PH (1) PH23982A (fi)
PT (1) PT81347B (fi)
RU (2) RU1836088C (fi)
SE (1) SE467520B (fi)
SG (1) SG80290G (fi)
UA (2) UA19169A (fi)
YU (1) YU46160B (fi)
ZA (1) ZA858033B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124317A (en) 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en) * 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
EP0438183B1 (en) * 1986-12-05 1995-11-08 PHARMACIA S.p.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
DE3801178A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
US6300361B1 (en) 1990-07-25 2001-10-09 Novartis Ag Stabilized pharmaceutical compositions comprising acid donors
ES2285743T3 (es) 1996-12-30 2007-11-16 Battelle Memorial Institute Uso de un farmaco anticancerigeno no encapsulado para la preparacion de una formulacion para tratar neoplasias mediante inhlacion.
US5942508A (en) * 1997-02-04 1999-08-24 Senju Pharmaceutical Co., Ltd. Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
SG161101A1 (en) 2002-02-22 2010-05-27 Schering Corp Pharmaceutical formulations of antineoplastic agents, in particular temozolomide processes of making and using the same
DK1474995T3 (da) * 2003-05-06 2013-02-18 Gumlink As Fremgangsmåde til fremstilling af tyggegummigranulater, et gummisammensætningsekstruder- og granuleringssystem og et tyggegummiprodukt
US20090099346A1 (en) * 2003-07-02 2009-04-16 Victor Matvienko Thermally stable crystalline epirubicin hydrochloride
CN100412084C (zh) * 2003-07-02 2008-08-20 獀洛克斯股份有限公司 热稳定的结晶盐酸表柔比星及其制造方法
US7314862B2 (en) * 2003-09-25 2008-01-01 Astellas Pharma Inc. Antitumor agent
US7388083B2 (en) * 2005-03-07 2008-06-17 Solux Corporation Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics
EP1814525A2 (en) * 2005-05-11 2007-08-08 Sicor Inc. Stable lyophilized anthracycline glycosides
BRPI0613034A8 (pt) 2005-07-14 2018-01-02 Lipothera Inc formulação injetável para acúmulo de tecido adiposo, formulação injetável e método para o tratamento de acúmulo de gordura, e, método para reduzir o tecido adiposo.
DE06848583T1 (de) * 2005-12-13 2011-03-17 Solux Corporation, San Diego Verfahren zur herstellung von 4-demethyldaunorubicin
US8802830B2 (en) * 2005-12-20 2014-08-12 Solux Corporation Synthesis of epirubicin from 13-dihydrodaunorubicine
US8148338B2 (en) * 2006-02-22 2012-04-03 Supratek Pharma Inc. Doxorubicin formulations for anti-cancer use
US7470672B2 (en) * 2006-07-31 2008-12-30 Savvipharm Inc. Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
BRPI0811248A2 (pt) * 2007-05-16 2014-11-04 Ktb Tumorforschungs Gmbh Formulação de antraciclina de baixa viscosidade.
MX2010001263A (es) * 2007-09-04 2010-10-04 Meiji Seika Kaisha Inyeccion, solucion de inyeccion y preparacion de equipo de inyeccion.
AU2008315718A1 (en) * 2007-10-26 2009-04-30 Pfizer Products Inc. Idarubicin for the treatment of lymphoma in a dog
US8357785B2 (en) * 2008-01-08 2013-01-22 Solux Corporation Method of aralkylation of 4′-hydroxyl group of anthracylins
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
CA2786618C (en) * 2010-01-15 2016-04-12 Lithera, Inc. Lyophilized cake formulations
CN103269693A (zh) 2010-11-24 2013-08-28 利赛拉公司 选择性、亲脂性及长效型β激动剂单一治疗调配物和用于肥胖及外形凸起的美容治疗的方法
DE102011103751A1 (de) 2011-05-31 2012-12-06 Heraeus Precious Metals Gmbh & Co. Kg Kristallisierung von Epirubicinhydrochlorid
DE102011111991A1 (de) * 2011-08-30 2013-02-28 Lead Discovery Center Gmbh Neue Cyclosporin-Derivate
EP3915369A1 (en) 2012-12-13 2021-12-01 CytRx Corporation Anthracycline formulations
JP2016521705A (ja) 2013-06-05 2016-07-25 サイトレックス コーポレイション がんを処置するための細胞傷害剤

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
US4039663A (en) * 1975-03-19 1977-08-02 Societa' Farmaceutici Italia S.P.A. Daunomycins, process for their uses and intermediates
GB1506200A (en) * 1975-04-30 1978-04-05 Farmaceutici Italia Glycosides
GB1567456A (en) * 1976-11-16 1980-05-14 Farmaceutici Italia Daunomycin derivatives
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
JPS563851A (en) * 1979-06-22 1981-01-16 Matsushita Electric Works Ltd Fireplace in floor
JPS5756494A (en) * 1980-09-22 1982-04-05 Microbial Chem Res Found New anthracyclin derivative
US4325947A (en) * 1981-05-12 1982-04-20 Farmitalia Carlo Erba S.P.A. 4-Demethoxy-4'-deoxydoxorubicin
IT1210476B (it) * 1981-05-28 1989-09-14 Erba Farmitalia Antracicline.
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides
DE3317702A1 (de) * 1982-05-24 1983-11-24 Farmitalia Carlo Erba S.p.A., 20159 Milano Anthracyclinglykoside, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
US4464529A (en) * 1982-07-20 1984-08-07 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
CA1248944A (en) * 1982-09-28 1989-01-17 Gareth J. Thomas Anthracycline glycosides
JPS5982395A (ja) * 1982-11-02 1984-05-12 Microbial Chem Res Found アントラサイクリン化合物、その製造法およびその用途
GR79729B (fi) * 1982-12-20 1984-10-31 Univ Ohio State Res Found
JPS6092212A (ja) * 1983-10-26 1985-05-23 Kyowa Hakko Kogyo Co Ltd ドキソルビシン塩の製剤
US4537882A (en) * 1984-05-10 1985-08-27 Ohio State University 4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same

Also Published As

Publication number Publication date
NO170616C (no) 1992-11-11
FR2571966B1 (fr) 1988-04-15
UA19169A (uk) 1997-12-25
GB8426672D0 (en) 1984-11-28
IE56992B1 (en) 1992-02-26
IT1186779B (it) 1987-12-16
US5091372A (en) 1992-02-25
FI853913A (fi) 1986-04-23
YU164485A (en) 1987-10-31
GB8525709D0 (en) 1985-11-20
US4840938A (en) 1989-06-20
US4675311A (en) 1987-06-23
CN85107562A (zh) 1986-07-23
ES8605374A1 (es) 1986-03-16
CH667594A5 (de) 1988-10-31
PT81347B (pt) 1987-11-11
NZ213885A (en) 1988-05-30
IL76732A0 (en) 1986-02-28
GR852549B (fi) 1986-02-24
UA34419C2 (uk) 2001-03-15
NO854194L (no) 1986-04-23
CA1248453A (en) 1989-01-10
AU4880585A (en) 1986-05-01
RU1836088C (ru) 1993-08-23
NL8502869A (nl) 1986-05-16
KR920005813B1 (ko) 1992-07-20
BE903484A (fr) 1986-04-21
SE8504945D0 (sv) 1985-10-21
SE467520B (sv) 1992-08-03
DK165620C (da) 1993-06-01
JPS61246129A (ja) 1986-11-01
AU572003B2 (en) 1988-04-28
FI854035L (fi) 1986-04-23
DK481585A (da) 1986-04-23
FI86252C (fi) 1992-08-10
PH23982A (en) 1990-02-09
CN85107562B (zh) 1988-06-01
CS756585A2 (en) 1989-11-14
NL191308B (nl) 1994-12-16
ES547578A0 (es) 1986-03-16
US5091373A (en) 1992-02-25
RU2101018C1 (ru) 1998-01-10
SE8504945L (sv) 1986-04-23
FR2571966A1 (fr) 1986-04-25
HK94390A (en) 1990-11-23
ZA858033B (en) 1986-06-25
ATA303285A (de) 1996-01-15
AT401345B (de) 1996-08-26
DE3536896A1 (de) 1986-04-24
CS270421B2 (en) 1990-06-13
KR860003014A (ko) 1986-05-19
DK481585D0 (da) 1985-10-21
PT81347A (en) 1985-11-01
DE3536896C2 (de) 1996-11-14
NO170616B (no) 1992-08-03
BG60934B2 (bg) 1996-06-28
FI854035A0 (fi) 1985-10-16
IT8522507A0 (it) 1985-10-16
SG80290G (en) 1990-11-23
DK165620B (da) 1992-12-28
GB2165751B (en) 1988-08-17
FI86252B (fi) 1992-04-30
YU46160B (sh) 1993-05-28
HUT40759A (en) 1987-02-27
HU197988B (en) 1989-07-28
IL76732A (en) 1989-07-31
NL191308C (nl) 1995-05-16
JPH0611700B2 (ja) 1994-02-16
MY103956A (en) 1993-10-30
GB2165751A (en) 1986-04-23
IE852593L (en) 1986-04-22

Similar Documents

Publication Publication Date Title
FI853913A0 (fi) Farmaceutiska foereningar som antracyklinglykosider.
FI860124A0 (fi) Staerkelsederivat som bildar reversibla geler.
FI884063A (fi) Hydrokrackningskatalysatorer och -foerfaranden som anvaender icke-zeolitiska molekylsaoll.
FI844125A0 (fi) Pappersmaskintyg som bestaor av slitstarka traodar.
FI853382A0 (fi) Stabilisering av polyetylentereftalat-polyoxietylentereftalatpolymerer som befraemjar smutslossning.
FI853650L (fi) Vaelsmakande tandkraem som foerhindrar uppkomsten av plack.
FI852078L (fi) Termoskanna eller -flaska med en tillslutningsslid som uppbaer tillslutningsorganet.
FI854942A0 (fi) Foerfarande foer kontinuerlig foeraedling av valsgods som utgaongsprodukt foer choklad.
FI852275L (fi) Blodpaose med en namnlapp som moegliggoer en oekad gasgenomslaepplighet.
FI852658L (fi) Farmaceutiska aemnen.
FI855010A (fi) Expansionsanordning som placerats i en trycksatt vaetskeberedare.
FI852504L (fi) Foerfarande foer framstaellning av kompositioner som foerhindrar uppkomst av tumoerer.
FI851338A0 (fi) Anordning foer utnyttjande av traeavfall som energikaella.
FI852586A0 (fi) Foerfarande foer framstaellning av en elastisk fibervals anvaendbar som en kalandervals.
FI852308L (fi) Metallo-organiska aluminater som tillsatsaemnen i smoerjmedel.
FI853381L (fi) Kompositioner som uppmjukar tvaettmedel under tvaettcykeln.
FI842771A0 (fi) Silanordning foer vatten som skall renas.
FI841106A0 (fi) En vaexlings- och reaktionskolonn som fungerar som provsamlare.
FI860347A0 (fi) Som traeskydd avsedd koppar- och kromhaltig saltblandning.
FI852646A0 (fi) Raevsax som doedar genast.
FI855187A0 (fi) Papperslaminat avsett isynnerhet som faestunderlag foer faestor.
FI864148A (fi) Keramisk fiberisolering som appliceras medelst besprutning.
FI853511A0 (fi) Modifierade staerkelser som utdrygningsmedel foer absorberande polymerer.
FI842774A0 (fi) Tillverkningsfoerfarande foer en gripplatta som skall monteras i betong.
FI912560A0 (fi) Foerfarande foer framstaellning av fysikaliska blandningar som innehaoller kefalosporinsalter.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: FARMITALIA CARLO ERBA S.P.A